BAY-2586116
- Generic Name
- BAY-2586116
BAY2586116 Nasal Spray and OSA Severity
- First Posted Date
- 2022-09-02
- Last Posted Date
- 2023-02-15
- Lead Sponsor
- Flinders University
- Target Recruit Count
- 10
- Registration Number
- NCT05527457
- Locations
- 🇦🇺
Flinders University, Bedford Park, South Australia, Australia
A Study to Learn More About How Safe BAY2586116 is, How it Affects the Body, How it Moves Into, Through and Out of the Body at Different Doses in Healthy Japanese Male Participants After Taking Single and Multiple Doses Through the Nose
- First Posted Date
- 2021-05-04
- Last Posted Date
- 2023-03-01
- Lead Sponsor
- Bayer
- Target Recruit Count
- 36
- Registration Number
- NCT04872387
- Locations
- 🇯🇵
SOUSEIKAI Fukuoka Mirai Hospital, Fukuoka, Japan
A Trial to Learn More About How Well BAY2586116 Works and How Safe it is in Participants With Moderate to Severe Obstructive Sleep Apnea
- First Posted Date
- 2021-01-19
- Last Posted Date
- 2022-10-26
- Lead Sponsor
- Bayer
- Target Recruit Count
- 93
- Registration Number
- NCT04713826
- Locations
- 🇩🇪
Ruhrlandklinik, Westdeutsches Lungenzentrum, Essen, Nordrhein-Westfalen, Germany
🇩🇪Advanced Sleep Research GmbH, Berlin, Germany
🇨🇭UniversitätsSpital Zürich, Zürich, Switzerland
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath